UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
concurrent chemoradiotherapy (968) 968
science & technology (965) 965
life sciences & biomedicine (960) 960
humans (816) 816
oncology (790) 790
female (698) 698
middle aged (664) 664
aged (587) 587
male (568) 568
adult (518) 518
cancer (438) 438
radiotherapy (430) 430
chemotherapy (426) 426
treatment outcome (327) 327
care and treatment (308) 308
neoplasm staging (280) 280
antineoplastic combined chemotherapy protocols - therapeutic use (271) 271
retrospective studies (256) 256
chemoradiotherapy (251) 251
prognosis (248) 248
combined modality therapy (235) 235
cisplatin - administration & dosage (229) 229
radiation therapy (229) 229
disease-free survival (206) 206
cisplatin (194) 194
nasopharyngeal carcinoma (192) 192
survival rate (190) 190
aged, 80 and over (175) 175
cervical cancer (172) 172
radiology, nuclear medicine & medical imaging (172) 172
patients (162) 162
chemoradiotherapy - methods (146) 146
squamous cell carcinoma (145) 145
survival (144) 144
concurrent chemoradiation (142) 142
carcinoma, squamous cell - therapy (140) 140
analysis (139) 139
induction chemotherapy (139) 139
research (138) 138
hematology, oncology and palliative medicine (137) 137
follow-up studies (135) 135
surgery (134) 134
survival analysis (134) 134
medicine & public health (132) 132
cancer therapies (129) 129
concurrent chemotherapy (127) 127
carcinoma, squamous cell - pathology (126) 126
carcinoma, squamous cell - radiotherapy (123) 123
radiotherapy dosage (122) 122
carcinoma, squamous cell - drug therapy (118) 118
carcinoma (117) 117
fluorouracil - administration & dosage (114) 114
chemoradiotherapy - adverse effects (112) 112
neoplasms. tumors. oncology. including cancer and carcinogens (111) 111
esophageal cancer (110) 110
toxicity (110) 110
metastasis (109) 109
radiation (108) 108
antineoplastic agents - therapeutic use (103) 103
antineoplastic combined chemotherapy protocols - adverse effects (103) 103
head and neck cancer (103) 103
carcinoma, squamous cell - mortality (100) 100
lung neoplasms - drug therapy (100) 100
medical prognosis (100) 100
lung neoplasms - radiotherapy (97) 97
cisplatin - therapeutic use (92) 92
carcinoma, non-small-cell lung - drug therapy (89) 89
lung neoplasms - pathology (89) 89
young adult (89) 89
carcinoma, non-small-cell lung - radiotherapy (86) 86
patient outcomes (84) 84
clinical trials (83) 83
lung cancer, non-small cell (83) 83
prospective studies (82) 82
non-small cell lung cancer (81) 81
uterine cervical neoplasms - pathology (81) 81
carcinoma, non-small-cell lung - pathology (80) 80
concurrent (80) 80
cisplatin - adverse effects (78) 78
kaplan-meier estimate (77) 77
uterine cervical neoplasms - therapy (76) 76
antimitotic agents (74) 74
antineoplastic agents (74) 74
drug administration schedule (74) 74
multivariate analysis (73) 73
antineoplastic agents - administration & dosage (71) 71
original (71) 71
studies (71) 71
lung cancer (70) 70
otorhinolaryngology (70) 70
docetaxel (69) 69
lung neoplasms - therapy (68) 68
usage (68) 68
cancer research (67) 67
health aspects (67) 67
original article (66) 66
carcinoma, non-small-cell lung - therapy (65) 65
chemotherapy, adjuvant (65) 65
risk factors (65) 65
head and neck neoplasms - drug therapy (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1463) 1463
Japanese (80) 80
Korean (33) 33
Chinese (19) 19
French (10) 10
Czech (6) 6
Polish (2) 2
Spanish (2) 2
Turkish (2) 2
Persian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 11, pp. 2043 - 2053
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 05/2017, Volume 8, Issue 46, pp. 80286 - 80294
.... We have now retrospectively evaluated the efficacy and safety of palliative chemoradiotherapy for patients with stage IV esophageal cancer, most of whom are unfit for curative chemoradiotherapy... 
Dysphagia | Advanced esophageal cancer | Survival | Concurrent chemoradiotherapy | Platinum doublet | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology
Journal Article
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 04/2017, Volume 75, pp. 14 - 23
Journal Article
Journal of radiation research, ISSN 1349-9157, 05/2015, Volume 56, Issue 3, pp. 568 - 576
Journal Article
Journal Article
Journal Article